EP2265272A4 - Adaptive biochemische signaturen - Google Patents

Adaptive biochemische signaturen

Info

Publication number
EP2265272A4
EP2265272A4 EP09723340A EP09723340A EP2265272A4 EP 2265272 A4 EP2265272 A4 EP 2265272A4 EP 09723340 A EP09723340 A EP 09723340A EP 09723340 A EP09723340 A EP 09723340A EP 2265272 A4 EP2265272 A4 EP 2265272A4
Authority
EP
European Patent Office
Prior art keywords
biochemical signatures
adaptive biochemical
adaptive
signatures
biochemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09723340A
Other languages
English (en)
French (fr)
Other versions
EP2265272A1 (de
Inventor
Desmond Mascarenhas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontherix Inc
Original Assignee
Ontherix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/077,575 external-priority patent/US7662624B2/en
Application filed by Ontherix Inc filed Critical Ontherix Inc
Publication of EP2265272A1 publication Critical patent/EP2265272A1/de
Publication of EP2265272A4 publication Critical patent/EP2265272A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30Unsupervised data analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Evolutionary Biology (AREA)
  • Artificial Intelligence (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioethics (AREA)
  • Chemical & Material Sciences (AREA)
  • Evolutionary Computation (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP09723340A 2008-03-19 2009-03-19 Adaptive biochemische signaturen Withdrawn EP2265272A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3801308P 2008-03-19 2008-03-19
US12/077,575 US7662624B2 (en) 2005-11-09 2008-03-19 Metal-binding therapeutic peptides
US15509109P 2009-02-24 2009-02-24
PCT/US2009/037695 WO2009117596A1 (en) 2008-03-19 2009-03-19 Adaptive biochemical signatures

Publications (2)

Publication Number Publication Date
EP2265272A1 EP2265272A1 (de) 2010-12-29
EP2265272A4 true EP2265272A4 (de) 2011-05-11

Family

ID=41091248

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09723340A Withdrawn EP2265272A4 (de) 2008-03-19 2009-03-19 Adaptive biochemische signaturen

Country Status (3)

Country Link
EP (1) EP2265272A4 (de)
CA (1) CA2718969A1 (de)
WO (1) WO2009117596A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662624B2 (en) * 2005-11-09 2010-02-16 Ontherix, Inc. Metal-binding therapeutic peptides
US8536135B2 (en) * 2008-03-19 2013-09-17 Ontherix, Inc. Adaptive biochemical signatures

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070072246A1 (en) * 2003-09-03 2007-03-29 Berg Ellen L Cell-based assays for determining drug action
US7906308B2 (en) * 2005-01-28 2011-03-15 Whitehead Institute For Biomedical Research Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
US8580854B2 (en) * 2005-11-09 2013-11-12 City Of Hope Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors
US20080039393A1 (en) * 2005-11-09 2008-02-14 Desmond Mascarenhas Metal-binding therapeutic peptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DANIELPOUR D ET AL: "Cross-talk between IGF-I and TGF-beta signaling pathways", CYTOKINE AND GROWTH FACTOR REVIEWS, ELSEVIER LTD, GB, vol. 17, no. 1-2, 1 February 2006 (2006-02-01), pages 59 - 74, XP024987937, ISSN: 1359-6101, [retrieved on 20060201], DOI: 10.1016/J.CYTOGFR.2005.09.007 *
SARBASSOV DOS D ET AL: "Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB", MOLECULAR CELL, vol. 22, no. 2, April 2006 (2006-04-01), pages 159 - 168, XP002630237, ISSN: 1097-2765 *
See also references of WO2009117596A1 *
WOO S-Y ET AL: "PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor [beta] expression and signaling", JOURNAL OF BIOLOGICAL CHEMISTRY 20070831 AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY INC. US, vol. 282, no. 35, 31 August 2007 (2007-08-31), pages 25604 - 25612, XP002630238, DOI: 10.1074/JBC.M704343200 *

Also Published As

Publication number Publication date
EP2265272A1 (de) 2010-12-29
WO2009117596A1 (en) 2009-09-24
CA2718969A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
AP3379A (en) Assays
EP2313129A4 (de) Tablettanordnung
GB0820262D0 (en) Microorganisms
GB0714246D0 (en) adaptive scheduling
PL2249996T3 (pl) Zszywacz
GB2462289B (en) Book
AU323629S (en) Lighter
GB0815068D0 (en) Insectical combinations
GB0821856D0 (en) Sheets
AU326165S (en) Stapler
HK1152978A1 (en) Rust-preventive sheet
EP2265272A4 (de) Adaptive biochemische signaturen
HK1134065A1 (en) Stapler with flat-clinch means
PL118319U1 (pl) Zszywacz
AU323630S (en) Lighter
GB0814284D0 (en) Synchysistic signatures
GB0721004D0 (en) Reducing radar signatures
GB0815849D0 (en) Sheets
GB0816334D0 (en) Sheets
GB0815553D0 (en) Flex stableisers
AU4043P (en) Fettuccini Acacia cognata
AU326017S (en) Stapler
TWM347289U (en) Document case
GB0808559D0 (en) Micro-organisms
AU2008901679A0 (en) Rivets

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031513000

Ipc: G01N0033500000

A4 Supplementary search report drawn up and despatched

Effective date: 20110413

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4745 20060101ALI20110404BHEP

Ipc: A61K 31/513 20060101ALI20110404BHEP

Ipc: G01N 33/50 20060101AFI20110404BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20111130

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120612